PerkinElmer Introduces Two New Microarrays For Apoptosis And Neurobiology Applications
New Microarrays Allow Researchers to Target Specific Genes in Profiling Experiments More Cost-Effectively
27-Feb-2002
BOSTON - February 26, 2002 - PerkinElmer Life Sciences, a
leading provider of technology solutions and services for drug
discovery, life science research and genetic disease screening, today
expanded its line of glass-based microarrays with the announcement of
two new microarrays -- one for apoptosis (programmed cell death) and one
for neurobiology applications. These microarrays, glass slides that have
smaller genes sets immobilized on them, are designed to enable
researchers to conduct more focused scientific research, more cost-effectively.
The Human apoptosis (MPS606) and Human Neurobiology (MPS607)
microarrays are additions to the MICROMAX Microarray product family. The
apoptosis microarray contains 333 genes plus 27 control genes, and the
neurobiology microarray contains 402 neurobiology genes plus 32 control
genes, each represented in duplicate, allowing ultimate, accurate and
precise gene profiling. In addition, each array has replicate spots of
non-human control genes, and a few blank spots increasing experimental
reliability. Each kit contains two microarrays and a technical data
sheet.
These new microarrays complement PerkinElmer Life Sciences' current
MICROMAX human focused-array line, which includes arrays containing
kinases and Phosphatases, transcription factors, oncogenes & tumor
suppressor genes, ion channels, transporter and receptor genes, as well
as the human 2,400 gene replicate-spotted screening microarray
introduced in 2001.
"PerkinElmer offers the broadest and most comprehensive line of
glass cDNA microarrays to the gene expression research community,"
said Frank Witney, president, Drug Discovery, PerkinElmer Life Sciences.
"We are committed to providing our customers with economical, robust and reproducible glass microarrays with proven and 100 percent
sequence-verified gene content for accurate and precise gene profiling.
With these new gene sets, researchers are now able to conduct more
focused scientific research at a significantly reduced cost."
The apoptosis and neurobiology microarrays are currently available,
combined with either the MICROMAX Direct Labeling Kit (MPS502) or the
MICROMAX TSA Labeling and Detection Kit (MPS522) for cDNA synthesis.
Also available for these new glass-based microarrays is the MICROMAX
Slide Scanning Service for scanning, data analysis and information
delivery using GeNet™, PerkinElmer's Web-based system. GeNet is a
licensed product from Silicon genetics.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
